ロード中...
Cancer therapy: reimbursement of new therapeutic technologies.
New drugs and technologies for cancer treatment are being developed at a rate that has created a reimbursement crisis. This article discusses third-party concerns about this problem and describes generic criteria that have proven to be useful in assessing any new technology. It is equally important...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Yale Journal of Biology and Medicine
1992
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2589524/ https://ncbi.nlm.nih.gov/pubmed/1519380 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|